<SEC-DOCUMENT>0000950170-25-029038.txt : 20250227
<SEC-HEADER>0000950170-25-029038.hdr.sgml : 20250227
<ACCEPTANCE-DATETIME>20250227161009
ACCESSION NUMBER:		0000950170-25-029038
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250227
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250227
DATE AS OF CHANGE:		20250227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Athira Pharma, Inc.
		CENTRAL INDEX KEY:			0001620463
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				453368487
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39503
		FILM NUMBER:		25678804

	BUSINESS ADDRESS:	
		STREET 1:		18706 NORTH CREEK PARKWAY, SUITE 104
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011
		BUSINESS PHONE:		(425) 620-8501

	MAIL ADDRESS:	
		STREET 1:		18706 NORTH CREEK PARKWAY, SUITE 104
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	M3 Biotechnology, Inc.
		DATE OF NAME CHANGE:	20140924
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>atha-20250227.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-27T14:47:57.7587+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:atha="http://athira.com/20250227" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_4c7e381d-5bda-4587-863d-4a1167d47b68" name="dei:EntityCentralIndexKey" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1">0001620463</ix:nonNumeric><ix:nonNumeric id="F_9cbeba8c-3df8-4bcb-b441-1432fbfe922b" name="dei:AmendmentFlag" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" format="ixt:fixed-false">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="atha-20250227.xsd"/></ix:references><ix:resources><xbrli:context id="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001620463</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-27</xbrli:startDate><xbrli:endDate>2025-02-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.6in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="agm_results"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, DC 20549</span></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:33.333%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3d86cd8b-5431-448a-8874-9a4b68c852af" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:33.333%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_87023081-3e72-4823-8729-614afb822e0a" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 27, 2025</span></ix:nonNumeric></span></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:33.333%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b25bdbf3-3218-4a33-af5a-3c3ff5bcd4a5" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Athira Pharma, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:33.333%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.34%;box-sizing:content-box;"/>
    <td style="width:33.34%;box-sizing:content-box;"/>
    <td style="width:33.32%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><span><ix:nonNumeric id="F_18a38abb-54c3-40d8-97b2-5ac73e6e3d93" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><span><ix:nonNumeric id="F_2a43ea7d-71b9-40b7-88a3-20cddd5d2fa2" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39503</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><span><ix:nonNumeric id="F_5cb4325f-87c0-49b3-ab29-d6e56ec0a4fc" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">45-3368487</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">of incorporation)</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File Number)</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8862c205-c3c0-4587-a7bd-65efa397a200" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18706 North Creek Parkway</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4244fc84-b370-45f3-aa02-42683cf40744" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Suite 104</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ee67a182-249f-49dc-a1e7-558e8ac6eb0f" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bothell</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b8c1c16f-59ac-43fd-87b5-06d590ec0706" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f834402a-615f-4448-aeea-3070d989505c" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98011</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices, including zip code)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1de490ab-6243-4d42-bc4b-2e3bd9d4688d" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">425</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2197375e-fae9-4900-94a5-303ae02bf244" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">620-8501</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former name or former address, if changed since last report)</span></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:33.333%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3.52%;box-sizing:content-box;"/>
    <td style="width:96.48%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_55c5649c-f6ae-447d-abd1-a25b3f85ed15" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_7262ed8f-f997-4887-9ff7-e324139a4875" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_9bb6ecb6-70c6-4eb5-9285-3cf70cb925cf" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_27b786a4-d172-4e62-93d2-fd1577581543" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:35%;box-sizing:content-box;"/>
    <td style="width:30%;box-sizing:content-box;"/>
    <td style="width:35%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_17bd055d-d4c5-4e2a-a0db-c786a04c421b" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_2c62fa6a-25f1-4fce-9437-d9d77248073c" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ATHA</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_428ad578-0d3e-4d6f-b7bf-a5e67f15b5e6" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;<br/>(The Nasdaq Global Select Market)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:75%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging Growth Company</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_edf66d99-56ed-4b37-a918-4940c1767f90" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act).  </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6f7a3d92-ba98-4f28-901a-01e860b49379" contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.6in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.6in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 27, 2025, Athira Pharma, Inc. (the &#8220;Company&#8221;) issued a press release reporting its financial results for the year ended December 31, 2024. A copy of the press release is furnished herewith as Exhibit 99.1.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tem 7.01 Regulation FD Disclosure.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls, the Company&#8217;s website (www.athira.com), its investor relations website (investors.athira.com), and its news site (investors.athira.com/news-and-events/press-releases). The Company uses these channels, as well as social media, including its X account (@athirapharma), LinkedIn account (www.linkedin.com/company/athirapharma), Instagram account (@athirapharma) and Facebook page (www.facebook.com/athirapharmainc), to communicate with investors and the public about the Company, its product candidates, and other matters. Therefore, the Company encourages investors, the media, and others interested in the Company to review the information it makes public in these locations, as such information could be deemed to be material information.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:90%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid;padding-right:0.028in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid;padding-right:0.028in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="atha-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Athira Pharma, Inc. press release dated February 27, 2025</span></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;text-align:right;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information furnished in this Current Report under Items 2.02 and 7.01 and exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.6in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.6in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Athira Pharma, Inc.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 27, 2025</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Mark Litton</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mark Litton</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.028in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.6in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>atha-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247042425_0.jpg" alt="img247042425_0.jpg" style="width:174px;height:86px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">On-track to enable dosing ALS patients in 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">BOTHELL, Wash., February 27, 2025 &#x2013; Athira Pharma, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results for the year ended December 31, 2024, and provided recent pipeline and business updates.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201c;We look forward to the opportunity to continue to advance ATH-1105 as a potential therapy for ALS, which in various preclinical models has demonstrated a consistent ability to improve motor and nerve function, enhance neuronal survival, and improve biomarkers of inflammation and neurodegeneration, including neurofilament light chain (NfL), a key marker of ALS disease progression,&#x201d; said Mark Litton, Ph.D, President and Chief Executive Officer of Athira. &#x201c;With the healthy volunteer Phase 1 clinical study of ATH-1105 complete, we are pleased to remain on track to enable dosing ALS patients in 2025.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Clinical Development &amp; Pipeline Programs</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Athira&#x2019;s drug development pipeline includes novel next-generation small molecule drug candidates designed to promote the neurotrophic hepatocyte growth factor (HGF) system, which activates neuroprotective, neurotrophic and anti-inflammatory pathways in the central and peripheral nervous system.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ATH-1105</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> &#x2013; A novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system for potential treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer&#x2019;s disease, and Parkinson&#x2019;s disease. ATH-1105 is currently in development for the potential treatment of ALS.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Athira conducted the first-in-human Phase 1 (</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NCT 06432647</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) double-blind, placebo-controlled clinical trial that enrolled 80 healthy volunteers to evaluate single and multiple oral ascending doses of ATH-1105. The study was completed in November 2024 and evaluated the safety and tolerability of ATH-1105 and included measurements of pharmacokinetic outcomes. The results of the Phase 1 trial showed that ATH-1105 demonstrated a favorable safety profile and was well-tolerated in healthy volunteers, supporting continued clinical development.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Athira is on track to enable dosing ALS patients in 2025.  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ATH-1105&#x2019;s potential is supported by a growing body of preclinical evidence demonstrating statistically significant improvements in nerve and motor function, biomarkers of inflammation and neurodegeneration, and survival in various models of ALS. </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">These data have been presented at a variety of key scientific and medical meetings including the American Association of Neurology (AAN), the Alzheimer&#x2019;s Association International Congress (AAIC), the Northeast Amyotrophic Lateral Sclerosis Consortium&#174; (NEALS), and the Motor Neurone Disease Association (MNDA), and published in </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Frontiers in Neuroscience</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, 2024.  </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Fosgonimeton (ATH-1017) &#x2013; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">A once daily, subcutaneously administered drug candidate initially targeted for the potential treatment of Alzheimer&#x2019;s disease.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In September 2024, Athira announced topline results from the LIFT-AD Phase 2/3 clinical trial of fosgonimeton in mild-to-moderate Alzheimer&#x2019;s disease. The study did not meet its primary or key secondary endpoints, but biomarker and subgroup data were directionally consistent with the broad neuroprotective mechanism of action. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exploration of Strategic Alternatives</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Following Athira&#x2019;s receipt of the topline results of LIFT-AD, the company made the determination to explore strategic alternatives focused on maximizing stockholder value. Athira engaged Cantor Fitzgerald &amp; Co. to act as an advisor in this process.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Additionally, Athira paused further development of fosgonimeton, including the related open label extension clinical trial, while continuing the development of ATH-1105 and exploring partnering options. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Financial Results</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cash Position. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and investments were $51.3 million as of December 31, 2024, compared to $147.4 million as of December 31, 2023. Net cash used in operations was $97.2 million for the year ended December 31, 2024, compared to $100.8 million for the year ended December 31, 2023.  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Research and Development (R&amp;D) Expenses.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> R&amp;D expenses were $70.7 million for the year ended December 31, 2024, compared to $93.8 million for the year ended December 31, 2023. The decrease was driven primarily by decreases in fosgonimeton program costs.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">General and Administrative (G&amp;A) Expenses.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> G&amp;A expenses were $26.1 million for the year ended December 31, 2024, compared to $33.3 million for the year ended December 31, 2023. The decrease was driven by decreases in legal, business development, and other general corporate expenses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Legal Expense. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Legal expense of $4.1 million was accrued during the year ended December 31, 2024, in connection with a settlement agreement reached with the United States Department of Justice related to Athira&#x2019;s NIH grant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net Loss.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> Net loss was $96.9 million, or $2.52 per share, for the year ended December 31, 2024, compared to a net loss of $117.7 million, or $3.09 per share, for the year ended December 31, 2023.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About Athira Pharma, Inc.<br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. Athira aims to alter the course of neurological diseases by advancing its pipeline of drug candidates that modulate the neurotrophic HGF system. For more information, visit </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">w</font></font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ww.athira.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. You can also follow Athira on </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Facebook</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">LinkedIn</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">X</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> and </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Instagram</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This communication contains &#x201c;forward-looking statements&#x201d; within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not based on historical fact and include statements regarding: Athira&#x2019;s drug candidates as potential treatments for amyotrophic lateral sclerosis, Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and other neurodegenerative diseases; future development plans; the potential learnings from preclinical studies and other nonclinical data and their ability to inform and improve future clinical development plans; the potential learnings from our Phase 1 ATH-1105 clinical trial and its implications for future development plans; expectations regarding the potential efficacy and commercial potential of Athira&#x2019;s drug candidates; Athira&#x2019;s ability to advance its drug candidates into later stages of development; and Athira&#x2019;s plans and expectations regarding Athira&#x2019;s exploration of strategic alternatives and partnering options. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;on track,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;plan,&#x201d; &#x201c;believe,&#x201d; &#x201c;intend,&#x201d; &#x201c;pursue,&#x201d; &#x201c;continue,&#x201d; &#x201c;suggest,&#x201d; &#x201c;potential,&#x201d; &#x201c;target,&#x201d; and similar expressions. Any forward-looking statements are based on management&#x2019;s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the data from preclinical and clinical trials may not support the safety, efficacy and tolerability of Athira&#x2019;s drug candidates; development of drug candidates may cease or be delayed; regulatory authorities could object to protocols, amendments and other submissions; future potential regulatory milestones for drug candidates, including those related to current and planned clinical studies, may be insufficient to support regulatory submissions or approval; whether Athira&#x2019;s trials are sufficiently powered to meet the planned endpoints; Athira may not be able to recruit sufficient patients for its clinical trials; the outcome of legal proceedings that have been or may in the future be instituted against Athira, its directors and officers; possible negative interactions of Athira's drug candidates with other treatments; Athira&#x2019;s assumptions regarding its financial condition and the sufficiency of its cash, cash equivalents and investments to fund its planned operations may be incorrect; adverse conditions in the general domestic and global economic markets; the impact of competition; the impact of drug candidate development and clinical activities on operating expenses; the impact of new or changing laws and regulations; risks related to Athira&#x2019;s exploration of strategic alternatives; as well as the other risks detailed in Athira&#x2019;s filings with the Securities and Exchange Commission from time to time. These forward-looking statements speak only as of the date hereof and Athira undertakes no obligation to update forward-looking statements. Athira may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on the forward-looking statements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Investor &amp; Media Contact:</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Julie Rathbun</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Athira Pharma</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Julie.rathbun@athira.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">206-769-9219</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Athira Pharma, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheets</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Amounts in thousands)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.84%;box-sizing:content-box;"></td>
    <td style="width:1.46%;box-sizing:content-box;"></td>
    <td style="width:1.52%;box-sizing:content-box;"></td>
    <td style="width:12.6%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.48%;box-sizing:content-box;"></td>
    <td style="width:1.52%;box-sizing:content-box;"></td>
    <td style="width:12.58%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;">December 31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;">December</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;">31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Helvetica LT Pro',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cdf2ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;Cash and cash equivalents</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">48,438</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">90,584</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#cdf2ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;Short-term investments</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">,837</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">56,835</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;Other short-term assets</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3,566</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">7,310</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cdf2ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;Other long-term assets</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3,938</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">5,516</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">58,779</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">160,245</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cdf2ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Liabilities and stockholders' equity</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;Current liabilities</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">13,135</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">28,840</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cdf2ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;Long-term liabilities</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">803</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">1,217</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">13,938</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">30,057</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cdf2ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Stockholders' equity</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">44,841</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">130,188</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' equity</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">58,779</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">160,245</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Athira Pharma, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Operations and Comprehensive Loss</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Amounts in thousands, except share and per share amounts)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:55.129%;box-sizing:content-box;"></td>
    <td style="width:4.679%;box-sizing:content-box;"></td>
    <td style="width:18.696%;box-sizing:content-box;"></td>
    <td style="width:2.799%;box-sizing:content-box;"></td>
    <td style="width:18.696%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Year Ended <br>December 31,</font></p></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2023</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$            70,682</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$            93,790</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;26,093</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;33,304</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Legal expense</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4,127</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Insurance recovery related to legal settlement</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1,628)</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:7.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="text-indent:7.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;100,902</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">125,466</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;(100,902)</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;(125,466)</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Grant income</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">157</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Other income, net</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3,962</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">   </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;7,637</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$         (96,940)</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$         (117,672)</font></p></td>
   </tr>
   <tr style="height:13.7pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale securities</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;350</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;1,607</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Comprehensive loss attributable to common stockholders</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$         (96,590)</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$         (116,065)</font></p></td>
   </tr>
   <tr style="height:27.35pt;background-color:#cdf3ff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss per share attributable to common stockholders,<br>&#160;&#160;&#160;basic and diluted</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$             (2.52)</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;$             (3.09)</font></p></td>
   </tr>
   <tr style="height:39.6pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Weighted-average shares used in computing net loss per<br>&#160;&#160;&#160;share attributable to common stockholders, basic<br>&#160;&#160;&#160;and diluted</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;38,480,875</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;38,020,182</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img247042425_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247042425_0.jpg
M_]C_X  02D9)1@ ! @$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %8 K4# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1132P!QS^'_ZZ %) !)(  )))   ZDD] .Y/ K\$/V]_VA?\
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M10 5DZIKVAZ&L3ZUK&F:2DY*PMJ5];62RLHRRQM<RQARHY(4D@<FM:OYT/\
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M34D^C5SY;#UI8:O1KP^*E4A->:C)-Q_[>5T_4_TNHR",@@@@$8Z8(X/IR/\
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MB!OVB/\ HD7PT_[_ .M__'J_%_\ 4/B+_H'P_P#X5T?\S[O_ %CRO_G[5_\
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M]O;G3=>_:-\ W6I6C%9M/\/W=SXBFRO!:.;1[6ZLI5SDYCNF! )&0,UYV/\
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MK<TK5/94JE2W-[.$IVO:_*F[7L[7MO9GOR_$/P"1G_A.?!_)./\ BIM%Z?\
M@;2_\+#\ ?\ 0\^#_P#PIM%_^3:_S;EOM0VK_P 3+4_NK_S$K[T'_3Q3OMVH
M?]!+4_\ P97W_P D5^H+PTA_T.)_^$*?_NUZ_P!/3Y'_ %KE_P! ,?GB'_\
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MO^"OG[ 7A^1H4^.5EXA9'"&3PSH6N:M"V2P+)(+&!612 &8# W+C.16'9_\
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MK)S4Y.FF[M*%]YRO^A</8.%# PQ#5ZV*CSRD]6J2=J4$[*R<4INR5W)+:*#
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MVV_Y5[2JG=6=*^]F>#Q!B)4\''#4V_;8VK"C!+=QYDYK_M[W8/NI/T?]$/\
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M>'<5]7S"-.3M#%1=)[6]I\5)OS;3@O\ &?U>T4@Z#Z#W_7O2U^&'Z&9VL?\
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M*S_@C!_RC_\ A5_V&_'G_J5:C7ZIU_.'$"MGN<;_ /(RQF_E7FOR2/U/+/\
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MEM<6EW!%=6MS$\%Q;7$:36\\,B[9(IHI%9)(W4E61P5(/(Q7Y1?M/?\ !/\
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MB)Q)'-9ZE:Q7<#I(GRL/+E R,#(KH*_(_P#X(S_'X_&;]D'0?#FIWGVOQ/\
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M_P#P6>_Y1\_%S_L-?#G_ -3O0J_B&7H/H/Y5_;S_ ,%GO^4?/Q<_[#7PY_\
M4[T*OXAEZ#Z#^5?M?AU_R(L1_P!C/$?^HV#/@^*/]_I?]@L/_3M86OZ>O^#=
M[_D6_P!IS_L8O '_ *9]5K^86OZ>O^#=[_D6_P!IS_L8O '_ *9]5KT>-_\
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M2*/@^)<9.IC%A%)JEAXQ<HJ]I59QC-R>MGRPE%1NM+RMNP Q_GV _I7ZO?\
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MQ/\ @C\2K:&.*Z\1^&-:\,ZA(H'F73Z-=Q7EG)+CYOW,5Y+&AQC#$#!Z_H'
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M/_4JU&OU3K\K/^",'_*/_P"%7_8;\>?^I5J-?JG7\X<0_P#(]SC_ +&6,_\
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M)J&,I\.ULP>%S_*:T)_6,DQT)1I3S/"TI/2I3Y8_7*%-\N,PT5.GSUH4)/\
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M_!T?\OZMZ'P%_P &_1S^T'\8CZ_#2S]/^@U ?7V_QK^M2OSG_8Y_X)H?!?\
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MZM&<5).+33<*CA*_72ZZ-O4_7_X _P#!5']COXZ:'IMT?BAHWPY\43Q1"_\
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M&XN[3Y9*ZZ.Y]U@Z4Z&$PU&I93I8>E3FD[KFA3C&5GU5T[,****\\Z0HHHH
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MBTK0=>I&6#QZ5M.9XS"5:TEI95XOJ%%%%?T,?SN%%%% !1110 4444 %%%%
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M1VVM>(=&TBYE@TGQR)XX-1U&WLYI("_C5XQ*D<S-$71T#A=R,N0>=_X+@_M
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OC;]M+X
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MG)1A#$T)SD]HQC5@Y-VUT2;TU,J\7*C6C%7E*E4C%=VX-)?-L_C)_P""-O\
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M]2I-)64E=^]*_P"\A*<&DW;E6U[G]208'CH>X]^^*_AW_P""SW_)_P#\9/\
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M_%'Q?X3\9:I!X8N-$\'0Z!;WJ?V7>:E+&NIZA<&_C0>8UBC6T'E@M&96?<I
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MNX2M3SW#U>5X%8'#8>O5Q$.;%4L)CG/%4<.Z-.E.C*U6;HO^R_'GQE\,N/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^RG^R_J2^(/AE\-K+_A+D3;#XO\ $<\OB#7[3*XD_L^[O]ZZ>9>"S6D<<@P
MCJ,@_;*KMSSG/M7%Q7Q9'/*=+!X.E4I8.E45:<ZRBJM:K&+C#W(2FH4X*4VK
MR<I2DFU%12>^39+++YSQ&(G"=>4'3BJ=W"G!M.6LDG*4G%+:T4K)N^CJ***^
M(/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>atha-20250227.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-27T14:47:57.8469+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://athira.com/20250227" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:atha="http://athira.com/20250227" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="atha-20250227.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46327107528160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 27,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Athira Pharma, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001620463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-39503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-3368487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">18706 North Creek Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bothell<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">620-8501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATHA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?E4#?-JP9PHN PP/X/[:-XG8IV$[^VVUJE^_!KU&LLK[?=JH_T?VJ'6.9(V
MM&PCX%';3QOS0A@LY7+%//_GY2_L4.=K&Z(&)9N?6'7G1@:O%^Q']\JV2"SC
MBKWQ. >6X7PUMG,D=U4"?-JS%XJ'-O_FNV0I:[.O06"R^$39JE\YOD^[\WO(
MV/TVB'BZAI,=;X/0TV1^-_F=8JJLWC_+ZN\34&L;I=]0P;8*,LEX6K^XM*!1
M.;ENE='[9ST?W&\9KF"J1=&I[1]C:K%HM9/[H'7TJ&Y?>WSE-A":Q;!"(?>J
MC]-5^S<)^Q,CL^+I?2F-D4EQ& ''/6HOP/]74IKW$_M"H'R?,_X74$L#!!0
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( $.!6UH'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ 0X%;6O/X;LKN    *P(  !$
M     ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 0X%;6IE<
MG",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    " !#@5M:"2![T8P$  #;$0  &               @($-
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 0X%;6I^@
M&_"Q @  X@P   T              ( !SPP  'AL+W-T>6QE<RYX;6Q02P$"
M% ,4    " !#@5M:EXJ[',     3 @  "P              @ &K#P  7W)E
M;',O+G)E;'-02P$"% ,4    " !#@5M:'#AEZC\!   \ @  #P
M    @ &4$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 0X%;6B0>FZ*M
M    ^ $  !H              ( ! !(  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ 0X%;6F60>9(9 0  SP,  !,
M ( !Y1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  +Q0
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="atha-20250227.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="atha-20250227.htm">atha-20250227.htm</File>
    <File>atha-20250227.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "atha-20250227.htm": {
   "nsprefix": "atha",
   "nsuri": "http://athira.com/20250227",
   "dts": {
    "inline": {
     "local": [
      "atha-20250227.htm"
     ]
    },
    "schema": {
     "local": [
      "atha-20250227.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "atha-20250227.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "atha-20250227.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://athira.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-029038-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-029038-xbrl.zip
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MG.1H&I&$Y76R>9.@]TJXN$C'>^1FYM?*5S[LBO!*;09A_;[,0!/'R&^0W9)
M)-D-XAY^1 PE'OV51'&"7"O.@85!$QQPLL@ +7N#I&"IR 9Y,B0Y*^(\&JJ:
M584L@*F788MJ\\E$ NH V@%\3X?UMRA+H'.LA\E/,88)<[*="T%^$:F08"B<
MI%!W4.YL.6@9K7*X.YWUWI/>Y%G.RWQLV0L3'^_6\IV6Y3TG7U)[7+;)RV9'
M&MZ#$YN6@K_WI#39H>U8?D@C4&FI9;F<LH#KE!EV8$:>+;C^[%T'O\NX@&7#
M?(!!6D4V\[N9D$&6)0$#KE# \CZ1=SZ0L'S7LO86J[DOGNSVTCBQ$O!6RPU(
M,[G>I#^Q8?%L $P,+-%*+,QL5,3]B=NZ2PX_GA'#U%I0\)M!\(;TGT3ZKN$8
M@GL1C7S?I9;GN=2/(I<*T[!TTV>6YSZ;],]!/PQA5=/+SR!60/-(&KI? X18
M"7C':TUZU6+?)7K=8E0W)NA^:E?RB.HMK566; A_^83O!X$#-.Q05PL=:HG
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MGM4:(^@+Y5GMMX.,#S_\L-_N%KWDP_\#4$L#!!0    ( $.!6UKEC?H9#PD
M &YI   1    871H82TR,#(U,#(R-RYX<V3M7>%SFS84_[Z_0G._M+=B;#=I
M%E^=79:T.]_2)A>GM]UVNQX&V>:&)4] XOSW>P+)02"P8P>PQ_HE!!Y/O_?3
MDQ _GIH//RWG'KK'S'<I&;2Z[4X+86)3QR730>OKR#@?70R'K9_.OOOPO6&@
MRT_#+^@+?D#G=N#>XTO7MSWJAPRCUZ//;]#O/]]>H9$]PW,+75([G&,2( /-
M@F#1-\V'AX>V,W&)3[TP@.;\MDWG)C(,X?R"88N?1Y=6@%&_U^D=&YV>T3NY
MZQ[UCT[ZQR?M'X_>G_[0Z?0[G<1M=/'(W.DL0*_M-XC?!6T3@CT//Z)/+K&(
M[5H>&LE6WZ(AL=OHW//0+;_-1[?8Q^P>.^W8Z=)W^GX<1&"Q*0Z^6'/L+RP;
M#UHB%"N8N<R*\/,&.[W>20M90<#<<1C@3Y3-+_'$"KU@T K)/Z'EN1,7.T"M
MASDGBD'B,O0%\?O@W"IN*;;#))SW5H;+,?/:E$VY6<?$RP 3WQU[V.!FF$7,
M^D:/=W!\.X2YNIEWS<,[<7NG:_[^^2KN1FGLN>1OQ3K17.>=R2^/+1]+\] W
MII:U6-TQL?QQ9"TN<)!'TMC!KAJ%C^WVE-Z;<$$QY!>=0!=QY]B,+R9-W0+
MD(4!),8*\#(3H*"C>WIZ:D976V??(10EASM?4!:@.$>NJ!UQ6] 8_\V0+1K\
ME-'M&>^Z;7#60B23705PS=U R'[:"L2JD[<%(3N)MWZ<UZZV5S=JT<_+'WY@
M\(/"-C-9][Q&M2EN8B_PY9E""/H1\@3!(H0&4;O\E#RY6+AD0N,S<([W4)]1
M#]\]+C#B!U]OAT53B1E82TKH_-'DQJ:<L^7/<^)\)($;/ ZA%3:/FF\A%^:-
MC2PE+HG,P3#[NU$,W0[_!\^&Q&-B=6@1!\7>4,+=!S/M).4^]+%S3<ZBXP6#
M.9W$A%W!"7&S,"FXT;8\._2>?]\3K-S;Q$G9/VJOR<$5L>N)V2;=K;=X4EJO
M1G-<?\;P9-#B3R!#>N,9^^HY/@((;M#R8=!X8JY0 K7&V.,<"6L.L6#2B2*(
MIE_IW0WX#2LW:JO1<\^!9^E3LZN&J:V8>GP<4Z9&OOD\\@I^^19S<.XXD&[^
M#85)VOO#75Q0!TNW$<Y!:XVQ625<6/Y0!A-:U&DC&"/X@H8D8(^%N(OOJC2
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M70F9"=9I?Z?W>J5WX>FDK9?=OR9VAZ4;5A6YBC>)[>7FFCW<<;&76V@.8G_
MP50+'\3.O8/?'_E_B7,CMR >U+ZK@]F:N,G'ACRT->WF7?_9+0]P+;O2_\/[
M")JZ26S/=Z@>V-;% ]['ML>[J/=R4^T![%(]T'U_+[YC-:DQO(A8L[ 8^#/L
MF>NML&U8*Z"^S5,&PWS0.CKE_]G; O#S5!FT8!T8^@"$+CAD/B5#"# 7,.Q<
MQ11L4FVTYTRD1 1!Q7&G@53D2!>2DFX#*=$+)9*17F,9R>@RDI)WC:5DC0HD
M"3IJ+$%)E4FR<=Q8-G*%+4G-^\92HY7/)"TG_].2%.HD+3\VG9:D)"A):>)Z
MMEA^%,R\;^+RMDCEE+PT<8VKRJF2B2:N;;,JKF2CB<O:'.%84M+$A:Q.II9\
M-'$I6Z2+2UZ:N(Y=+\!+=IJXG,UJ_)*-)JYB4Y\5)!5-7+OJ/V8(1DZ:NV;-
M^78BB6GBHC7_&XUDI>P%K*AE35>.2@-9ZNK&?Z8A/OW!3/T5#G$B\;<ZXC/Q
M7PXY^Q=02P,$%     @ 0X%;6JM2/1PL'@  2\8!  \   !A=&AA+65X.3E?
M,2YH=&WM75EWVT:R?K^_HJ\3)_(Y(,V=(NGD7(V7Q',4QS?VG)EYNJ<)-,F.
M #0&#4AB?OVMJ@9(<)&LA0M(MA\L"4LOU55?;=V%-Y,D\'_^+_9F(K@'/]F;
M1":^^/G]ORJ]7K7^YK7Y$QYXG3WQ9JB\*=/)U!<_O8BXY\EPW#^/;@<!C\<R
M[/,T4?\M@TC%"0^3P0MJU)/72Z]4$A7U:]6V# =_563HB=M^I3D(9%B9"#F>
M)/TZW(F4EHE483\6/D_DM1@,U6U%R[^PSZ&*/1%7X IT\B;*VQ^I,,%'1+]>
MBY)L5*:W =T;\4#ZT_Y7&0C-/HD;]H<*>)@_.%1)H@)X-A&W287[<@R]XX"P
M$WP_[\=5OHK[W]7HW^!F(A-1T1%W13^*1>4FYI'I[L9,9ZA\;U 86QW&5AS.
MCV^AKV$L?W0T#W5%BUB.S -7(@YQOJ$*!1'H1GK)I#^22<6%^X*(_/YV(H<R
M86;1\+V?W[R.MDL6%[H6,=)%!F.F8_>G%_!+H]6MM1JM1OO_:M4_H_$+QOUD
M_8UL9&8Z]6X+>"A;^_-.1(N*,W@-O$,\M)NI%)?X[D6=]WY?AP]?OA^^JW=J
M@\+"[6?"S^3IUF9Y^B*9R)BSSQ,>!YS](1!2-/N0^C[[M^ Q:]0:+?9!ACQT
M)??A 9WZ\  //?991L*7H: __I9J^%5K]H_(XXG0>R?SM_AJPW0\,.8R8VD\
MF ;4?%\F<-]]!%7>JB#R12(\!HK-3R93=JW\%.Z*&%E."U9G+O"0=(&W=)*"
MTE,C=O'UUTJ]7FLS#HS&(H6-(?,EL>!) '^PD8H9#Z8JB54TD2X#Q25B;,+U
M10SZ3+.SB\LOK_:^')M; ,N$3V;"WV&2,7>O6**8"/G0%\P#'@G'#'B$16#S
MP'.:R1#!KKU#ZOEBM&+Q?(M:&S9I=LXQZ^9<+BOO;[]__?7]Y:7#_LGUI.JP
M#V(8ISR>LD;7(0YA/WQWVZC5FP.VH#P=]C%TJSDIGRX/&YX.._MT\>7=Q?_V
M$58O7CF J 7$Y6/!AA) %&?@BC2AZR[ -@^G +-NJ@&\5<@\<2U\%:'4Z("#
M=1 H7[BI#^L.8A4+G:A8L%"DL0JA!0/W9!EH7]V8&YX8BQ!P&KT-!U[S^!3>
M1(L#^AC-;(PXLS$0Y).)8%.T0P1X+QY[)UP1#$%Y-.NT%BV'NHAB=2WQ?BP0
MD5A4M$R&N662&LND:B6\M!*^)0J@N+J#?PKF*W6%?'7#8P_Y%ME+1<B!:2B3
M*5["]V28"OR=>]? D^)N@V0"W!Q-B5-!ES@,9N9.4)-<\UBJ5 -GBIFT!2
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M#OU$ *PJ=PKWQK&Z 8 ?<1?5X-FOOWQXQ?04M&60ZUNX TH/VZ8VH-%$X"7
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M%1367!OA[H/Y'@2+T!:A-XW08#<],HK'F&5/RYY;9\\,B^<V_]QZ!Y[-L!0
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M,C(W+FAT;5!+ 0(4 Q0    ( $.!6UKEC?H9#PD  &YI   1
M  "  8H5  !A=&AA+3(P,C4P,C(W+GAS9%!+ 0(4 Q0    ( $.!6UJK4CT<
M+!X  $O& 0 /              "  <@>  !A=&AA+65X.3E?,2YH=&U02P4&
2      ,  P"[    (3T

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>atha-20250227_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atha-20250227.xsd" xlink:type="simple"/>
    <context id="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001620463</identifier>
        </entity>
        <period>
            <startDate>2025-02-27</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_4c7e381d-5bda-4587-863d-4a1167d47b68">0001620463</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_9cbeba8c-3df8-4bcb-b441-1432fbfe922b">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_3d86cd8b-5431-448a-8874-9a4b68c852af">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_87023081-3e72-4823-8729-614afb822e0a">2025-02-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_b25bdbf3-3218-4a33-af5a-3c3ff5bcd4a5">Athira Pharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_18a38abb-54c3-40d8-97b2-5ac73e6e3d93">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_2a43ea7d-71b9-40b7-88a3-20cddd5d2fa2">001-39503</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_5cb4325f-87c0-49b3-ab29-d6e56ec0a4fc">45-3368487</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_8862c205-c3c0-4587-a7bd-65efa397a200">18706 North Creek Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_4244fc84-b370-45f3-aa02-42683cf40744">Suite 104</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_ee67a182-249f-49dc-a1e7-558e8ac6eb0f">Bothell</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_b8c1c16f-59ac-43fd-87b5-06d590ec0706">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_f834402a-615f-4448-aeea-3070d989505c">98011</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_1de490ab-6243-4d42-bc4b-2e3bd9d4688d">425</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_2197375e-fae9-4900-94a5-303ae02bf244">620-8501</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_55c5649c-f6ae-447d-abd1-a25b3f85ed15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_7262ed8f-f997-4887-9ff7-e324139a4875">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_9bb6ecb6-70c6-4eb5-9285-3cf70cb925cf">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_27b786a4-d172-4e62-93d2-fd1577581543">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_17bd055d-d4c5-4e2a-a0db-c786a04c421b">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_2c62fa6a-25f1-4fce-9437-d9d77248073c">ATHA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_428ad578-0d3e-4d6f-b7bf-a5e67f15b5e6">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_edf66d99-56ed-4b37-a918-4940c1767f90">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_bc66aecb-efd0-4a43-85af-6c6f2d60f2b1"
      id="F_6f7a3d92-ba98-4f28-901a-01e860b49379">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
